Solventum Corporation
SOLV
$85.26
-$0.01-0.01%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.28% | 2.21% | 1.29% | 0.70% | 0.60% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.28% | 2.21% | 1.29% | 0.70% | 0.60% |
| Cost of Revenue | 6.92% | 7.19% | 7.77% | 3.94% | 1.73% |
| Gross Profit | -1.32% | -1.56% | -3.47% | -1.73% | -0.26% |
| SG&A Expenses | 19.99% | 25.64% | 29.35% | 22.52% | 15.71% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.81% | 13.00% | 14.47% | 10.05% | 6.49% |
| Operating Income | -43.32% | -44.96% | -48.94% | -35.37% | -22.36% |
| Income Before Tax | 69.79% | -75.53% | -80.71% | -63.65% | -40.75% |
| Income Tax Expenses | -44.87% | -122.48% | -118.66% | -60.44% | -5.40% |
| Earnings from Continuing Operations | 111.67% | -64.08% | -70.62% | -64.41% | -47.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 111.67% | -64.08% | -70.62% | -64.41% | -47.86% |
| EBIT | -43.32% | -44.96% | -48.94% | -35.37% | -22.36% |
| EBITDA | -31.70% | -33.99% | -37.36% | -26.81% | -17.94% |
| EPS Basic | 110.04% | -64.28% | -70.75% | -64.48% | -33.03% |
| Normalized Basic EPS | -67.34% | -69.01% | -75.91% | -60.01% | -23.04% |
| EPS Diluted | 109.37% | -64.50% | -70.92% | -64.56% | -33.23% |
| Normalized Diluted EPS | -67.52% | -69.15% | -76.00% | -60.07% | -23.09% |
| Average Basic Shares Outstanding | 0.51% | 0.48% | 0.42% | 0.28% | 33.56% |
| Average Diluted Shares Outstanding | 1.02% | 0.98% | 0.85% | 0.55% | 33.72% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |